Scientists a step closer to treatment of virulent hospital infectionMarch 19th, 2011 - 4:35 pm ICT by ANI
Washington, Mar 19 (ANI): Researchers from the University of Calgary and the National Research Council of Canada say they are gaining a deeper understanding of Clostridium difficile and are closer to developing a novel treatment using antibodies from llamas.
Clostridium difficile is a health problem that affects hundreds of thousands of patients and costs 10 billion dollars to 20 billion dollars every year in North America.
“We have found that relatively simple antibodies can interfere with the disease-causing toxins from C. difficile,” says paper co-author Dr. Kenneth Ng, an associate professor of biological sciences at the University of Calgary and principal investigator of the Alberta Ingenuity Centre for Carbohydrate Science. “This discovery moves us a step closer to understanding how to neutralize the toxins and to create novel treatments for the disease.”
Approximately two percent of all patients admitted to hospital may be infected by C. difficile, which thrives when healthy bacteria in the gut are weakened by antibiotics, thus allowing spores from Clostridium to germinate and colonize the large intestine.
C. difficile produces two toxins — toxin A (TcdA) and toxin B (TcdB) — which cause damage to intestinal cells by binding to carbohydrates on the cell surface and disrupting cell functions such as adhesion. The new research shows that what’s known as single-domain antibodies bind to the C. difficile toxins with high affinity and interfere with the toxins’ ability to damage cells.
“Llamas have normal antibodies like our own, but they have also developed a second type of antibody with a simpler structure. It is this simpler structure that allows us to make modifications and perform many detailed studies that are not easily done with other types of antibodies,” says Ng.
The research is part of a paper published in the print issue of the Journal of Biological Chemistry. (ANI)
- New superbug behind fatal colon infections - Apr 03, 2011
- Llama proteins are potential bioterrorism weapons - Jan 21, 2010
- Scientists reveal how superbug turns killer - Oct 17, 2011
- Newly identified spider toxin may help treat pain, human diseases - Mar 10, 2011
- Antibodies that prevent HIV from infecting human cells found - Jul 09, 2010
- Novel discoveries offer new ways to design HIV vaccine - Sep 30, 2010
- Indians discover world's most heat-resistant fungi - Jul 23, 2011
- US scientists grow cold-causing virus on sinus tissue - Apr 11, 2011
- Pump that bacteria use to resist drugs described - Feb 27, 2011
- Novel synthetic molecules boost immune response to HIV and prostate cancer - Nov 06, 2009
- New antibodies to combat Alzheimer's - Dec 12, 2011
- Map of herpes virus protein suggests new target for antiviral drugs - Jul 07, 2010
- Scientists unravel herpes virus protein structure - Jul 27, 2010
- Good guys among bacteria bolster our immune system - Jun 15, 2010
- How bacteria give a boost to the immune system - Jun 15, 2010
Tags: alberta ingenuity, cell functions, cell surface, clostridium, damage cells, deeper understanding, dr kenneth, health problem, intestinal cells, journal of biological chemistry, large intestine, national research council, national research council of canada, novel treatment, novel treatments, paper co, research council of canada, tcda, types of antibodies, university of calgary